Publications

  1. Cummins NW, Badley AD. Anti-apoptotic mechanisms of HIV: lessons and novel approaches to curing HIV. Cell Mol Life Sci. 2012 Dec 30. [Epub ahead of print] 2292427
    View PubMed
  2. Trushin SA, Carena AA, Bren GD, Rizza SA, Dong X, Abraham RS, Badley AD. SDF-1alpha degrades whereas glycoprotein 120 upregulates Bcl-2 interacting mediator of death extralong isoform: implications for the development of T cell memory. J Immunol. 2012 Aug 15; 189(4):1835-42. Epub 2012 Jul 16. 2258392
    View PubMed
  3. Cummins NW, Weaver EA, May SM, Croatt AJ, Foreman O, Kennedy RB, Poland GA, Barry MA, Nath KA, Badley AD. Heme oxygenase-1 regulates the immune response to influenza virus infection and vaccination in aged mice. FASEB J. 2012 Jul; 26(7):2911-8. Epub 2012 Apr 06. 2245620
    View PubMed
  4. Baker JV, Neuhaus J, Duprez D, Freiberg M, Bernardino JI, Badley AD, Nixon DE, Lundgren JD, Tracy RP, Neaton JD, INSIGHT SMART Study Group. HIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction. J Acquir Immune Defic Syndr. 2012 Jun 1; 60(2):128-34. 2247709
    View PubMed
  5. Schnepple DJ, Shepard B, Bren GD, Cummins NW, Natesampillai S, Trushin S, Algeciras-Schimnich A, Meng XW, Sainski AM, Rizza SA, Kaufmann SH, Badley AD. Isolation of a TRAIL antagonist from the serum of HIV-infected patients. J Biol Chem. 2011 Oct 14; 286(41):35742-54. Epub 2011 Aug 22. 2187735
    View PubMed
  6. Sainski AM, Natesampillai S, Cummins NW, Bren GD, Taylor J, Saenz DT, Poeschla EM, Badley AD. The HIV-1-specific protein Casp8p41 induces death of infected cells through Bax/Bak. J Virol. 2011 Aug; 85(16):7965-75. Epub 2011 Jun 08. 2169993
    View PubMed
  7. Cummins NW, Klicpera A, Sainski AM, Bren GD, Khosla S, Westendorf JJ, Badley AD. Human immunodeficiency virus envelope protein Gp120 induces proliferation but not apoptosis in osteoblasts at physiologic concentrations. PLoS One. 2011; 6(9):e24876. Epub 2011 Sep 12. 2192281
    View PubMed
  8. Rizza SA, Challagundla KB, Natesampillai S, Bren GD, Sykora J, Walczak H, Badley AD. TRAIL dependent fratricidal killing of gp120 primed hepatocytes by HCV core expressing hepatocytes. PLoS One. 2011; 6(11):e27171. Epub 2011 Nov 14. 2208779
    View PubMed
  9. Rizza SA, Cummins NW, Rider DN, Saeed S, Klein MB, Badley AD. Polymorphism in tumor necrosis factor-related apoptosis-inducing ligand receptor 1 is associated with poor viral response to interferon-based hepatitis C virus therapy in HIV/hepatitis C virus-coinfected individuals. AIDS. 2010 Nov 13; 24(17):2639-44. 2112304
    View PubMed
  10. Cummins NW, Jiang W, McGinty J, Bren GD, Bosch RJ, Landay A, Deeks SG, Martin JN, Douek D, Lederman MM, Brenchley J, Badley AD. Intracellular Casp8p41 content is inversely associated with CD4 T cell count. J Infect Dis. 2010 Aug 15; 202(3):386-91. 2103459
    View PubMed
  11. Taylor JA, Cummins NW, Bren GD, Rizza SA, Kolbert CP, Behrens MD, Knutson KL, Kahl JC, Asmann YW, Badley AD. Casp8p41 expression in primary T cells induces a proinflammatory response. AIDS. 2010 Jun 1; 24(9):1251-8. 1992862
    View PubMed
  12. Trushin SA, Bren GD, Badley AD. CXCR4 Tropic HIV-1 gp120 Inhibition of SDF-1alpha-Induced Chemotaxis Requires Lck and is Associated with Cofilin Phosphorylation. Open Virol J. 2010; 4:157-62. Epub 2010 Jun 23. 2114834
    View PubMed
  13. Cummins NW, Badley AD. Mechanisms of HIV-associated lymphocyte apoptosis: 2010. Cell Death Dis. 2010; 1:e99. Epub 2010 Nov 11. 2151559
    View PubMed
  14. Natesampillai S, Nie Z, Cummins NW, Jochmans D, Bren GD, Angel JB, Badley AD. Patients with discordant responses to antiretroviral therapy have impaired killing of HIV-infected T cells. PLoS Pathog. 2010; 6(11):e1001213. Epub 2010 Nov 24. 2129816
    View PubMed
  15. Singh VP, Bren GD, Algeciras-Schimnich A, Schnepple D, Navina S, Rizza SA, Dawra RK, Saluja AK, Chari ST, Vege SS, Badley AD. Nelfinavir/ritonavir reduces acinar injury but not inflammation during mouse caerulein pancreatitis. Am J Physiol Gastrointest Liver Physiol. 2009 May; 296(5):G1040-6. Epub 2009 Mar 12. 1931929
    View PubMed
  16. Cummins N, Badley A. The TRAIL to viral pathogenesis: the good, the bad and the ugly. Curr Mol Med. 2009 May; 9(4):495-505. 1949895
    View PubMed
  17. O'Hara SP, Small AJ, Gajdos GB, Badley AD, Chen XM, Larusso NF. HIV-1 Tat protein suppresses cholangiocyte toll-like receptor 4 expression and defense against Cryptosporidium parvum. J Infect Dis. 2009 Apr 15; 199(8):1195-204. 1929740
    View PubMed
  18. Shepard BD, Badley AD. The Biology of TRAIL and the Role of TRAIL-Based Therapeutics in Infectious Diseases. Antiinfect Agents Med Chem. 2009 Apr 1; 8(2):87-101. 2187727
    View PubMed
  19. Trushin SA, Bren GD, Badley AD. CD4 T Cells Treated with gp120 Acquire a CD45R0+/CD45RA+ Phenotype. Open Virol J. 2009; 3:21-5. Epub 2009 Apr 01. 1950967
    View PubMed
  20. Bren GD, Trushin SA, Whitman J, Shepard B, Badley AD. HIV gp120 induces, NF-kappaB dependent, HIV replication that requires procaspase 8. PLoS One. 2009; 4(3):e4875. Epub 2009 Mar 16. 1931914
    View PubMed
  21. Babu CK, Suwansrinon K, Bren GD, Badley AD, Rizza SA. HIV induces TRAIL sensitivity in hepatocytes. PLoS One. 2009; 4(2):e4623. Epub 2009 Feb 27. 1928113
    View PubMed
  22. van de Beek D, Patel R, Campeau NG, Badley A, Parisi JE, Rabinstein AA, Manno EM, Wijdicks EF. Insidious sinusitis leading to catastrophic cerebral aspergillosis in transplant recipients. Neurology. 2008 Jun 10; 70(24 Pt 2):2411-3. 1883295
    View PubMed
  23. Shepard BD, Loutfy MR, Raboud J, Mandy F, Kovacs CM, Diong C, Bergeron M, Govan V, Rizza SA, Angel JB, Badley AD. Early changes in T-cell activation predict antiretroviral success in salvage therapy of HIV infection. J Acquir Immune Defic Syndr. 2008 Jun 1; 48(2):149-55. 1888367
    View PubMed
  24. Hisatomi T, Nakazawa T, Noda K, Almulki L, Miyahara S, Nakao S, Ito Y, She H, Kohno R, Michaud N, Ishibashi T, Hafezi-Moghadam A, Badley AD, Kroemer G, Miller JW. HIV protease inhibitors provide neuroprotection through inhibition of mitochondrial apoptosis in mice. J Clin Invest. 2008 Jun; 118(6):2025-38. 1909305
    View PubMed
  25. Rizza SA, Badley AD. HIV protease inhibitors impact on apoptosis. Med Chem. 2008 Jan; 4(1):75-9. 1872142
    View PubMed
  26. Rizza SR, Tangalos EG, McClees MD, Strausbauch MA, Targonski PV, McKean DJ, Wettstein PJ, Badley AD. Nelfinavir monotherapy increases naive T-cell numbers in HIV-negative healthy young adults. Front Biosci. 2008; 13:1605-9. Epub 2008 Jan 01. 1853573
    View PubMed
  27. Nie Z, Bren GD, Rizza SA, Badley AD. HIV Protease Cleavage of Procaspase 8 is Necessary for Death of HIV-Infected Cells. Open Virol J. 2008; 2:1-7. 1915605
    View PubMed
  28. Shepard BD, De Forni D, McNamara DR, Foli A, Rizza SA, Abraham RS, Knutson K, Wettstein PJ, Lori F, Badley AD. Beneficial effect of TRAIL on HIV burden, without detectable immune consequences. PLoS One. 2008; 3(8):e3096. Epub 2008 Aug 28. 1915694
    View PubMed
  29. Bren GD, Whitman J, Cummins N, Shepard B, Rizza SA, Trushin SA, Badley AD. Infected cell killing by HIV-1 protease promotes NF-kappaB dependent HIV-1 replication. PLoS One. 2008; 3(5):e2112. Epub 2008 May 07. 1894729
    View PubMed
  30. Vlahakis SR, Bren GD, Algeciras-Schimnich A, Trushin SA, Schnepple DJ, Badley AD. Flying in the face of resistance: antiviral-independent benefit of HIV protease inhibitors on T-cell survival. Clin Pharmacol Ther. 2007 Sep; 82(3):294-9 Epub 2007 Mar 14. 1839130
    View PubMed
  31. Nie Z, Bren GD, Vlahakis SR, Schimnich AA, Brenchley JM, Trushin SA, Warren S, Schnepple DJ, Kovacs CM, Loutfy MR, Douek DC, Badley AD. Human immunodeficiency virus type 1 protease cleaves procaspase 8 in vivo. J Virol. 2007 Jul; 81(13):6947-56. Epub 2007 Apr 18. 1832963
    View PubMed
  32. Tracz MJ, Juncos JP, Grande JP, Croatt AJ, Ackerman AW, Rajagopalan G, Knutson KL, Badley AD, Griffin MD, Alam J, Nath KA. Renal hemodynamic, inflammatory, and apoptotic responses to lipopolysaccharide in HO-1-/- mice. Am J Pathol. 2007 Jun; 170(6):1820-30. 1828157
    View PubMed
  33. Vlahakis SR, Bennett SAL, Whitehead SN, Badley AD. HIV protease inhibitors modulate apoptosis signaling in vitro and in vivo. Apoptosis. 2007 May; 12(5):969-77. 1822441
    View PubMed
  34. Trushin SA, Algeciras-Schimnich A, Vlahakis SR, Bren GD, Warren S, Schnepple DJ, Badley AD. Glycoprotein 120 binding to CXCR4 causes p38-dependent primary T cell death that is facilitated by, but does not require cell-associated CD4. J Immunol. 2007 Apr 15; 178(8):4846-53. 1818764
    View PubMed
  35. Murali NS, Ackerman AW, Croatt AJ, Cheng J, Grande JP, Sutor SL, Bram RJ, Bren GD, Badley AD, Alam J, Nath KA. Renal upregulation of HO-1 reduces albumin-driven MCP-1 production: implications for chronic kidney disease. Am J Physiol Renal Physiol. 2007 Feb; 292(2):F837-44. Epub 2006 Sep 12. 1807178
    View PubMed
  36. O'Hara SP, Small AJ, Nelson JB, Badley AD, Chen XM, Gores GJ, Larusso NF. The human immunodeficiency virus type 1 tat protein enhances Cryptosporidium parvum-induced apoptosis in cholangiocytes via a Fas ligand-dependent mechanism. Infect Immun. 2007 Feb; 75(2):684-96. Epub 2006 Nov 21. 1807150
    View PubMed
  37. Algeciras-Schimnich A, Belzacq-Casagrande A, Bren GD, Nie Z, Taylor JA, Rizza SA, Brenner C, Badley AD. Analysis of HIV Protease Killing Through Caspase 8 Reveals a Novel Interaction Between Caspase 8 and Mitochondria. Open Virology J , PMC2548302 2007, 1; 139-46. PMCID:39-46. 1990163
  38. Assi MA, Binnicker MJ, Wengenack NL, Deziel PJ, Badley AD. Disseminated coccidioidomycosis in a liver transplant recipient with negative serology: use of polymerase chain reaction. Liver Transpl. 2006 Aug; 12(8):1290-2. 1775771
    View PubMed
  39. Chui C, Cheung PK, Brumme CJ, Mo T, Brumme ZL, Montaner JS, Badley AD, Harrigan PR. HIV VprR77Q mutation does not influence clinical response of individuals initiating highly active antiretroviral therapy. AIDS Res Hum Retroviruses. 2006 Jul; 22(7):615-8. 1772847
    View PubMed
  40. Vlahakis SR, Badley AD. Influence of proteasome inhibitors on apoptosis. Curr Opin Clin Nutr Metab Care. 2006 Jan; 9(1):42-7. 1750549
    View PubMed
  41. Silvestri G, Lori F, Foli A, Montaner LJ, Clotet B, Barreiro P, Gatell JM, Poli G, Lederman M, Perno CF, Wainberg MA, Lieberman J, Bentwitch Z, Cooper DA, Badley A, Kinloch S, Miller S, Youle M, Autran B, Lisziewicz J, Weiner DB, Ensoli B, Franchini G, Introduction. J Acquir Immune Defic Syndr. 2006; 42(3 SUPPL. 1):S1-S27. 1972065
    View PubMed
  42. Graham DB, Bell MP, Huntoon CJ, Weaver JGR, Hawley N, Badley AD, McKean DJ. Increased thymic output in HIV-negative patients after antiretroviral therapy. AIDS. 2005 Sep 23; 19(14):1467-72. 1732048
    View PubMed
  43. Pittock ST, Norby SM, Grande JP, Croatt AJ, Bren GD, Badley AD, Caplice NM, Griffin MD, Nath KA. MCP-1 is up-regulated in unstressed and stressed HO-1 knockout mice: Pathophysiologic correlates. Kidney Int. 2005 Aug; 68(2):611-22. 1726795
    View PubMed
  44. Badley AD. In vitro and in vivo effects of HIV protease inhibitors on apoptosis. Cell Death Differ. 2005 Aug; 12 Suppl 1:924-31. 1726818
    View PubMed
  45. Trushin SA, Bren GD, Asin S, Pennington KN, Paya CV, Badley AD. Human immunodeficiency virus reactivation by phorbol esters or T-cell receptor ligation requires both PKCalpha and PKCtheta. J Virol. 2005 Aug; 79(15):9821-30. 1720461
    View PubMed
  46. Lum JJ, Schnepple DJ, Badley AD. Acquired T-cell sensitivity to TRAIL mediated killing during HIV infection is regulated by CXCR4-gp120 interactions. AIDS. 2005 Jul 22; 19(11):1125-33. 1729825
    View PubMed
  47. Lum JJ, Bren G, McClure R, Badley AD. Elimination of senescent neutrophils by TNF-related apoptosis-inducing [corrected] ligand. J Immunol. 2005 Jul 15; 175(2):1232-8. 1726747
    View PubMed
  48. Weaver JG, McGregor CG, Tazelaar HD, Badley AD. Rejection severity directly correlates with myocyte apoptosis in pig-to-baboon cardiac xenotransplantation. J Heart Lung Transplant. 2005 Jul; 24(7):841-7. 1977490
    View PubMed
  49. Weaver JGR, Tarze A, Moffat TC, LeBras M, Deniaud A, Brenner C, Bren GD, Morin MY, Phenix BN, Dong L, Jiang SX, Sim VL, Zurakowski B, Lallier J, Hardin H, Wettstein P, van Heeswijk RPG, Douen A, Kroemer RT, Hou ST, Bennett SAL, Lynch DH, Kroemer G, Inhibition of adenine nucleotide translocator pore function and protection against apoptosis in vivo by an HIV protease inhibitor. J Clin Invest. 2005 Jul; 115(7):1828-38. 1721466
    View PubMed
  50. Anson BD, Weaver JGR, Ackerman MJ, Akinsete O, Henry K, January CT, Badley AD. Blockade of HERG channels by HIV protease inhibitors. Lancet. 2005 Feb 19; 365(9460):682-6. 1694420
    View PubMed
  51. Cuerrier D, Nie Z, Badley AD, Davies PL. Ritonavir does not inhibit calpain in vitro. Biochemical & Biophysical Research Communications. 2005 Feb 4; 327(1):208-11. 1680817
    View PubMed
  52. Weaver JGR, Rouse MS, Steckelberg JM, Badley AD. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis. FASEB J. 2004 Aug; 18(11):1185-91. 1657421
    View PubMed
  53. Buenz EJ, Badley AD. Impact of mitochondrial regulation of apoptosis on the pathogenesis and treatment of HIV-1-induced immunodeficiency. Mitochondrion. 2004 Jul; 4(2-3):235-54. 1673787
    View PubMed
  54. Lum JJ, Schnepple DJ, Nie Z, Sanchez-Dardon J, Mbisa GL, Mihowich J, Hawley N, Narayan S, Kim JE, Lynch DH, Badley AD. Differential effects of interleukin-7 and interleukin-15 on NK cell anti-human immunodeficiency virus activity. J Virol. 2004 Jun; 78(11):6033-42. 1647014
    View PubMed
  55. Zhang XP, Lalezari JP, Badley AD, Dorr A, Kolis SJ, Kinchelow T, Patel IH. Assessment of drug-drug interaction potential of enfuvirtide in human immunodeficiency virus type 1-infected patients. Clinical Pharmacology & Therapeutics. 2004 Jun; 75(6):558-68. 1649274
    View PubMed
  56. Owen C, Kazim F, Badley AD. Effect on CD4 T-cell count of replacing protease inhibitors in patients with successful HIV suppression: a meta-analysis. AIDS. 2004 Mar 5; 18(4):693-5. 1642996
    View PubMed
  57. Cohen I, Boya P, Zhao L, Metivier D, Andreau K, Perfettini JL, Weaver JG, Badley A, Taylor EW, Kroemer G. Anti-apoptotic activity of the glutathione peroxidase homologue encoded by HIV-1. Apoptosis. 2004 Mar; 9(2):181-92. 1639232
    View PubMed
  58. Cooper CL, Phenix B, Mbisa G, Lum JJ, Parato K, Hawley N, Angel JB, Badley AD. Antiretroviral therapy influences cellular susceptibility to apoptosis in vivo. Front Biosci. 2004 Jan; 9:338-41. 1429171
    View PubMed
  59. Buenz EJ, Weaver JG, Bauer BA, Chalpin SD, Badley AD. Cordyceps sinensis extracts do not prevent Fas-receptor and hydrogen peroxide-induced T-cell apoptosis. J Ethnopharmacol. 2004 Jan; 90(1):57-62. 1517880
    View PubMed
  60. Lum JJ, Badley AD. Resistance to apoptosis: Mechanism for the development of HIV reservoirs. Current HIV Research. 2003 Jul; 1(3):261-74. 1517816
    View PubMed
  61. Jiang JQ, Balasubramanian S, Hawley-Foss NC, Badley AD, Rosenthal KL, Copeland KF. Production of CD8+ T cell nonlytic suppressive factors by CD28, CD38, and HLA-DR subpopulations. AIDS Res Hum Retroviruses. 2003 Jun; 19(6):497-502. 2171374
    View PubMed
  62. Badley AD, Roumier T, Lum JJ, Kroemer G. Mitochondrion-mediated apoptosis in HIV-1 infection. Trends Pharmacol Sci. 2003 Jun; 24(6):298-305. 1404289
    View PubMed
  63. Narayan S, Hawley N, Giguere P, Badley AD. Attenuated T-lymphocyte response to HIV therapy in individuals receiving HMG-CoA reductase inhibitors. HIV Clinical Trials. 2003 May-Jun; 4(3):164-9. 1422322
    View PubMed
  64. Lum JJ, Cohen OJ, Nie ZL, Weaver JG, Gomez TS, Yao XJ, Lynch D, Pilon AA, Hawley N, Kim JE, Chen ZX, Montpetit M, Sanchez-Dardon J, Cohen EA, Badley AD. Vpr R77Q is associated with long-term nonprogressive HIV infection and impaired induction of apoptosis. J Clin Invest. 2003 May; 111(10):1547-54. 1355623
    View PubMed
  65. Nie Z, Phenix BN, Lum JJ, Alam A, Lynch DH, Beckett B, Krammer PH, Sekaly RP, Badley AD. HIV-1 protease processes procaspase 8 to cause mitochondrial release of cytochrome c, caspase cleavage and nuclear fragmentation. Cell Death & Differentiation. 2002 Nov; 9(11):1172-84. 1316691
    View PubMed
  66. Phenix BN, Cooper C, Owen C, Badley AD. Modulation of apoptosis by HIV protease inhibitors. Apoptosis. 2002 Aug; 7(4):295-312. 1314809
    View PubMed
  67. Pilon AA, Lum JJ, Sanchez-Dardon J, Phenix BN, Douglas R, Badley AD. Induction of apoptosis by a nonnucleoside human immunodeficiency virus type 1 reverse transcriptase inhibitor. Antimicrobial Agents & Chemotherapy. 2002 Aug; 46(8):2687-91. 1315014
    View PubMed
  68. Walmsley S, Bernstein B, King M, Arribas J, Beall G, Ruane P, Johnson M, Johnson D, Lalonde R, Japour A, Brun S, Sun E, M98-863 Study Team. Lopinavir-ritonavir versus nelfinavir for the initial treatment of HIV infection. N Engl J Med. 2002 Jun 27; 346(26):2039-46. 2176107
    View PubMed
  69. Phenix BN, Badley AD. Influence of mitochondrial control of apoptosis on the pathogenesis, complications and treatment of HIV infection. Biochimie. 2002 Feb; 84(2-3):251-64. 1215160
    View PubMed
  70. Bergeron R, Nicholson JKA, Phaneuf S, Ding T, Soucy N, Badley A, Hawley-Foss NC, Mandy F. Selection of lymphocyte gating protocol has an impact on the level of reliability of T-cell subsets in aging specimens. Cytometry. 2002; 50(2):53-61. 2171367
  71. Parato KG, Kumar A, Badley AD, Sanchez-Dardon J, Chambers KA, Young CD, Lim WT, Kravcik S, Cameron DW, Angel JB. Normalization of natural killer cell function and phenotype with effective anti-HIV therapy and the role of interleukin-10. AIDS. 2002; 16(9):1251-6. 1215162
    View PubMed
  72. Mikhael J, Humphrey S, Jabi M, Badley AD. Atypical cause of pulmonary infiltrate in a typical patient. Can J Infect Dis. 2002; 13:71-2. 1215150
  73. Hawley-Foss N, Mbisa G, Lum JJ, Pilon AA, Angel JB, Garber G, Badley AD. Effect of therapy cessation during a discordant response to highly active antiretroviral therapy: implications for scheduled therapeutic interruptions. Clin Infect Dis. 2002; 34:553-6. 1215158
    View PubMed
  74. Lum JJ, Pilon AA, Sanchez-Dardon J, Phenix BN, Kim JE, Mihowich J, Jamison K, Hawley-Foss N, Lynch DH, Badley AD. Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l. J Virol. 2001 Nov; 75(22):11128-36. 1215122
    View PubMed
  75. Teixeira L, Valdez H, McCune JM, Koup RA, Badley AD, Hellerstein MK, Napolitano LA, Douek DC, Mbisa G, Deeks S, Harris JM, Barbour JD, Gross BH, Francis IR, Halvorsen R, Asaad R, Lederman MM. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. AIDS. 2001 Sep 28; 15(14):1749-56. 1979808
    View PubMed
  76. Phenix BN, Lum JJ, Nie Z, Sanchez-Dardon J, Badley AD. Antiapoptotic mechanism of HIV protease inhibitors: preventing mitochondrial transmembrane potential loss. Blood. 2001 Aug 15; 98(4):1078-85. 1215133
    View PubMed
  77. Hawley-Foss N, Mbisa G, Lum JJ, Pilon AA, Angel JB, Garber G, Badley AD. Effect of cessation of highly active antiretroviral therapy during a discordant response: implications for scheduled therapeutic interruptions. Clin Infect Dis. 2001 Aug 1; 33(3):344-8. Epub 2001 Jun 21. 1215121
    View PubMed
  78. Maslove DM, Ni LW, Hawley-Foss NC, Badley AD, Copeland KF. Modulation of HIV transcription by CD8(+) cells is mediated via multiple elements of the long terminal repeat. Clin Exp Immunol. 2001 Jul; 125(1):102-9. 2171365
    View PubMed
  79. Cooper CL, Badley AD, Angel JB. Characteristics of hepatitis C virus infection in HIV-infected people. Can J Infect Dis. 2001 May; 12(3):157-63. 1215128
    View PubMed
  80. Kravcik S, Magill A, Sanghvi B, Ogden R, Cameron WD, Lewis R, Yu G, Badley AD. Comparative CD4 T-cell responses of reverse transcriptase inhibitor therapy with or without nelfinavir matched for viral exposure. HIV Clin Trials. 2001 Mar-Apr; 2(2):160-70. 1215119
    View PubMed
  81. Giguere P, Badley AD. Issues concerning therapy with HIV protease inhibitors. Clinical Perspectives in HIV Therapy. The Medicine Group Ltd. 2001:1-18. 1215147
  82. Angel JB, Parato KG, Kumar A, Kravcik S, Badley AD, Fex C, Ashby D, Sun E, Cameron WD. Progressive human immunodeficiency virus specific immune recovery with prolonged viral suppression. J Inf Dis. 2001; 183:546-54. 1215127
  83. Kim WR, Badley AD, Wiesner RH, Porayko MK, Seaberg EC, Keating MR, Evans RW, Dickson ER, Krom RA, Paya CV. The economic impact of cytomegalovirus infection after liver transplantation. Transplantation. 2000 Feb 15; 69(3):357-61. 129495
    View PubMed
  84. Phenix BN, Angel J, Mandy F, Parato K, Chambers KA, Kravcik S, Hawley-Foss N, Cassol S, Cameron DW, Badley AD. Decreased HIV associated T cell apoptosis by HIV protease inhibitors. AIDS Res & Hum Retro. 2000; 6:559-67. 1215050
  85. Badley AD, Pilon AA, Landay A, Lynch DH. Mechanisms of HIV associated lymphocyte apoptosis. Blood. 2000; 96:2951-64. 1215060
    View PubMed
  86. Lauzon W, Sanchez Dardon J, Cameron DW, Badley AD. Flow cytometric measurement of telomere length. Cytometry. 2000; 42:159-64. 1215069
    View PubMed
  87. Khaliq Y, Gallicano K, Seguin I, Fyke K, Carignan G, Bulman D, Badley A, Cameron DW. Single and multiple dose pharmacokinetics of nelfinavir and CYP2C19 activity in human immunodeficiency virus-infected patients with chronic liver disease. Br J Clin Pharmacol. 2000; 50:108-15. 1215103
    View PubMed
  88. Khaliq Y, Gallicano K, Leger R, Foster B, Badley A. A drug interaction between fusidic acid and a combination of ritonavir and saquinavir. Br J Clin Pharmacol. 2000; 50:81-3. 1215114
    View PubMed
  89. Dockrell DH, Badley AD, Algeciras-Schimnich A, Simpson M, Schut R, Lynch DH, Paya CV. Activation-induced CD4+ T cell death in HIV-positive individuals correlates with Fas susceptibility, CD4+ T cell count, and HIV plasma viral copy number. AIDS Res Hum Retroviruses. 1999 Nov 20; 15(17):1509-18. 125031
    View PubMed
  90. Badley AD, Parato K, Cameron DW, Kravcik S, Phenix BN, Ashby D, Kumar A, Lynch DH, Tschopp J, Angel JB. Dynamic correlation of apoptosis and Immune activation during treatment of HIV infection. Cell Death and Differentiation. 1999; 6:420-32. 1215039
    View PubMed
  91. Hunt RH, Fallone CA, Badley AD, Thomson ABR. For the Canadian Helicobacter Study Group (CHSG). Update to the Canadian Consensus Conference on Helicobacter pylori infections in adults Can J Gastroenterol. 1999; 13:213-7. 1215042
  92. Kravcik S, Gallicano K, Roth V, Cassol S, Hawley-Foss N, Badley A, Cameron DW. Cerebrospinal fluid HIV RNA and drug levels with combination ritonavir and saquinavir. JAIDS. 1999; 21:371-5. 1215043
    View PubMed
  93. Kravcik S, Victor G, Angel JB, Badley AD, Garber GE, Cameron DW. Activity of the combination of nelfinavir and saquinavir against human immunodeficiency virus after failure of prior protease inhibitor therapy. Clin Inf Dis. 1999; 29:702-3. 1215044
  94. Falagas ME, Paya C, Ruthazer R, Badley A, Patel R, Wiesner R, Griffith J, Freeman R, Rohrer R, Werner BG, Snydman DR. Significance of cytomegalovirus for long-term survival after orthotopic liver transplantation: a prospective derivation and validation cohort analysis. Transplantation. 1998 Oct 27; 66(8):1020-8. 108343
    View PubMed
  95. O'Connor WJ, Badley AD, Dicken CH, Murphy GM. Porphyria cutanea tarda and human immunodeficiency virus: two cases associated with hepatitis C. Mayo Clin Proc. 1998 Sep; 73(9):895-7. 1018967
    View PubMed
  96. Badley AD, Dockrell DH, Algeciras A, Ziesmer S, Landay A, Lederman MM, Connick E, Kessler H, Kuritzkes D, Lynch DH, Roche P, Yagita H, Paya CV. In vivo analysis of Fas/FasL interactions in HIV-infected patients. J Clin Invest. 1998 Jul 1; 102(1):79-87. 107051
    View PubMed
  97. Dockrell DH, Badley AD, Villacian JS, Heppelmann CJ, Algeciras A, Ziesmer S, Yagita H, Lynch DH, Roche PC, Leibson PJ, Paya CV. The expression of Fas Ligand by macrophages and its upregulation by human immunodeficiency virus infection. J Clin Invest. 1998 Jun 1; 101(11):2394-405. 105758
    View PubMed
  98. Holtz-Heppelmann CJ, Algeciras A, Badley AD, Paya CV. Transcriptional regulation of the human FasL promoter-enhancer region. J Biol Chem. 1998 Feb 20; 273(8):4416-23. 103323
    View PubMed
  99. Dockrell DH, Prada J, Jones MF, Patel R, Badley AD, Harmsen WS, Ilstrup DM, Wiesner RH, Krom RA, Smith TF, Paya CV. Seroconversion to human herpesvirus 6 following liver transplantation is a marker of cytomegalovirus disease. J Infect Dis. 1997 Nov; 176(5):1135-40. 100750
    View PubMed
  100. Badley AD, Seaberg EC, Porayko MK, Wiesner RH, Keating MR, Wilhelm MP, Walker RC, Patel R, Marshall WF, DeBernardi M, Zetterman R, Steers JL, Paya CV. Prophylaxis of cytomegalovirus infection in liver transplantation: a randomized trial comparing a combination of ganciclovir and acyclovir to acyclovir. NIDDK Liver Transplantation Database. Transplantation. 1997 Jul 15; 64(1):66-73. 99200
    View PubMed
  101. Badley AD, Dockrell D, Simpson M, Schut R, Lynch DH, Leibson P, Paya CV. Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor. J Exp Med. 1997 Jan 6; 185(1):55-64. 101571
    View PubMed
  102. Badley AD, Dockrell D, Paya CV. Apoptosis in AIDS. Adv Pharmacol. 1997; 41:271-94. 100212
  103. Das M, Badley AD, Cockerill FR, Steckelberg JM, Wilson WR. Infective endocarditis caused by HACEK microorganisms. Annu Rev Med. 1997; 48:25-33. 101778
    View PubMed
  104. Patel R, Portela D, Badley AD, Harmsen WS, Larson-Keller JJ, Ilstrup DM, Keating MR, Wiesner RH, Krom RA, Paya CV. Risk factors of invasive Candida and non-Candida fungal infections after liver transplantation. Transplantation. 1996 Oct 15; 62(7):926-34. 97982
    View PubMed
  105. Badley AD, Steckelberg JM, Wollan PC, Thompson RL. Infectious rates of central venous pressure catheters: comparison between newly placed catheters and those that have been changed. Mayo Clin Proc. 1996 Sep; 71(9):838-46. 97749
    View PubMed
  106. Badley AD, Portela DF, Patel R, Kyle RA, Habermann TM, Strickler JG, Ilstrup DM, Wiesner RH, de Groen P, Walker RC, Paya CV. Development of monoclonal gammopathy precedes the development of Epstein-Barr virus-induced posttransplant lymphoproliferative disorder. Liver Transpl Surg. 1996 Sep; 2(5):375-82. 98001
    View PubMed
  107. Badley AD, van Scoy RE. Long-term follow-up of multifocal osteoarticular sporotrichosis treated with itraconazole. Clin Infect Dis. 1996 Aug; 23(2):394-5. 1316498
    View PubMed
  108. Patel R, Badley AD, Larson-Keller J, Harmsen WS, Ilstrup DM, Wiesner RH, Steers JL, Krom RA, Portela D, Cockerill FR, Paya CV. Relevance and risk factors of enterococcal bacteremia following liver transplantation. Transplantation. 1996 Apr 27; 61(8):1192-7. 96037
    View PubMed
  109. Badley AD, Patel R, Portela DF, Harmsen WS, Smith TF, Ilstrup DM, Steers JL, Wiesner RH, Paya CV. Prognostic significance and risk factors of untreated cytomegalovirus viremia in liver transplant recipients. J Infect Dis. 1996 Feb; 173(2):446-9. 95602
    View PubMed
  110. Badley AD, McElhinny JA, Leibson PJ, Lynch DH, Alderson MR, Paya CV. Upregulation of Fas ligand expression by human immunodeficiency virus in human macrophages mediates apoptosis of uninfected T lymphocytes. J Virol. 1996 Jan; 70(1):199-206. 95414
    View PubMed
  111. Lynch DH, Campbell KA, Miller RE, Badley AD, Paya CV. FasL/Fas and TNF/TNFR interactions in the regulation of immune responses and disease Behring Inst Mitt , 1996; 97:1-10. 151482
  112. MacMorran WS, Badley AD, Wilson WR. 26-year-old man with HIV infection and abdominal pain. Mayo Clin Proc. 1995 Sep; 70(9):885-8. 93526
    View PubMed
  113. Badley AD, Camilleri M, O'Connor MK. Noninvasive measurement of human ascending colon volume. Nucl Med Commun. 1993 Jun; 14(6):485-9. 85647
    View PubMed
  114. Schlech W, Chase DP, Badley AD. A model of food-borne Listeria monocytogenes infection in the Sprague Dauley rat using gastric innoculation; development and effect of gastric acidity on infective dose. Int J Food Microbiology. 1993; 18(1):15-24. 1215031
  115. Badley AD, MacCormick RE, LeBrun GP. Neoplastic imitators of small bowel Crohn's disease. Can J Gastroenterol. 1992; 6(2):77-83. 1215029
  116. Badley AD, Phillips B, Haldane D, Dalton M. Pathogenic marine Vibrio species in selected Nova Scotian recreational coastal waters. Can J Pub Health. 1990; 81:263-7. 1215023